D-Wave Quantum shares closed at $29.40 on Friday, May 22, after a volatile session driven by news of a potential $100 million grant from the CHIPS and Science Act. The stock traded between $25.61 and $31.54, with volume reaching approximately 141.7 million shares. U.S. markets are closed Monday for Memorial Day, giving investors time to digest the implications.
Grant Details and Market Reaction
The proposed funding, announced last week, is part of a broader U.S. government push to advance quantum computing. D-Wave would issue $100 million in common stock to the Commerce Department if final agreements are signed. The grant is not yet finalized, and the company faces a series of milestones and negotiations before the funds are disbursed.
D-Wave is one of several companies selected for quantum-related CHIPS Act funding. IBM is set to receive $1 billion for a quantum chip project, GlobalFoundries $375 million for quantum components, and Rigetti Computing and Infleqtion each about $100 million. This allocation highlights the government's focus on both annealing and gate-model quantum systems, with D-Wave specializing in annealing for optimization tasks.
Financial Performance and Outlook
D-Wave's first-quarter results showed a mixed picture. Bookings surged to $33.4 million, driven by a $20 million system sale to Florida Atlantic University and a $10 million quantum service deal with a Fortune 100 company. However, revenue plummeted 81% to $2.9 million, reflecting a tough comparison with the prior year when a large system sale was recorded. The net loss widened to $18.4 million, or 5 cents per share, as operating costs rose.
The company ended March with $588.4 million in cash and marketable securities, providing a substantial buffer. Still, converting bookings into revenue remains a key challenge, and the stock's valuation hinges on the commercial scalability of quantum technology.
Investor Day and Risks Ahead
D-Wave will hold its first investor day on June 1 at the New York Stock Exchange, with a webcast available. The company plans to discuss its technology roadmap, commercial progress, and long-term growth strategy. Given the recent stock surge, analysts expect tougher questions on revenue visibility and the timeline for profitability.
Risks remain significant. The CHIPS Act grant requires final documentation, project milestones, and continued federal funding. Issuing shares to the government would dilute existing shareholders. D-Wave also faces low quarterly sales, ongoing losses, and a market cap near $10.8 billion that relies on future commercial success.
In the week ahead, trading will likely focus on whether investors view government backing as a catalyst or a distraction. If final funding appears imminent, the rally could extend. Delays or stricter conditions might embolden bears and short sellers.
